| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/2012 | CN102311957A Hydatidovis soluble antigen preparation method and product thereof |
| 01/11/2012 | CN102311936A Bacillus thuringiensis strain and parasporal crystal thereof, extraction method of parasporal crystal, and application of the two in controlling plant nematode disease |
| 01/11/2012 | CN102311928A Recombinant yeast engineering strain coexpressed by proteins of chicken anaemia viruses VP1 and VP2, construction method thereof and application thereof |
| 01/11/2012 | CN102311497A Method for recovering albumin from component IV deposition by low temperature ethanol method |
| 01/11/2012 | CN102311496A Method for recovering alhumin from deposited components I+II+III from cold ethanol method |
| 01/11/2012 | CN102311495A Novel recombinant human blood coagulation factor VIII and production method thereof |
| 01/11/2012 | CN102311494A Method for extracting human chorionic gonadotropin (HCG) |
| 01/11/2012 | CN102311493A Peptide inhibiting telomerase activity, its preparation method and application |
| 01/11/2012 | CN102311492A Non-natural fully D-type snake venom cathelicidin antibacterial peptide and derivative, preparation method as well as application thereof |
| 01/11/2012 | CN102311491A Plant heat-resistant gene HSF1 and application thereof |
| 01/11/2012 | CN102311490A Plant heat-resistant gene JAZ5a and application thereof |
| 01/11/2012 | CN102311489A Plant heat-resistant gene BccDREB2A and application thereof |
| 01/11/2012 | CN102311488A Relevant protein EdHP1 utilizing plant nutrients efficiently, encoding gene and application thereof |
| 01/11/2012 | CN102311487A Anti-HIV (Human Immunodeficiency Virus) infection polypeptide, composition and application |
| 01/11/2012 | CN102002507B Method for improving expression quantity of target gene in plant by utilizing CsMADS1 gene |
| 01/11/2012 | CN101845439B Method for using silkworm cultured cell to express antibacterial peptide Cecropin B |
| 01/11/2012 | CN101698678B Silkworm antibacterial peptide, cDNA sequence thereof and application thereof |
| 01/11/2012 | CN101696238B Plant total protein extracting solution and application thereof |
| 01/11/2012 | CN101638438B Human epididymis protease profilin immunological contraception polypeptide |
| 01/11/2012 | CN101560252B Method for extracting zein by microwave |
| 01/11/2012 | CN101319216B Preparation for recombined cultivated silkworm antimicrobial peptide CM4 and purification process |
| 01/11/2012 | CN101307317B Method for preparing rabies virus antigen |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101189335B Leptin antagonists |
| 01/11/2012 | CN101157921B Method for cultivating drought-resistant and /or growth-delaying plant in hostile environment |
| 01/11/2012 | CN101157920B Method for cultivating drought-resistant and /or growth-delaying plant in hostile environment |
| 01/10/2012 | US8093454 Transgene assay using stable agrobacterium rhizogenes transformation |
| 01/10/2012 | US8093450 Non-aggregating fluorescent proteins and methods for using the same |
| 01/10/2012 | US8093368 DR5 gene promoter and SIAH-1 gene promoter |
| 01/10/2012 | US8093365 Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same |
| 01/10/2012 | US8093363 Tumor necrosis factor-gamma |
| 01/10/2012 | US8093359 Optimized Fc variants and methods for their generation |
| 01/10/2012 | US8093356 Pegylated human interferon polypeptides |
| 01/10/2012 | US8093355 Soluble IL-17RCx4 and fusion proteins thereof |
| 01/10/2012 | US8093353 Screening compounds which disrupt the association of helices with cytoplasmic membranes |
| 01/10/2012 | US8093209 Methods of suppressing microglial activation and systemic inflammatory responses |
| 01/10/2012 | US8093206 Methods involving long lasting synthetic exendin-4 peptide conjugates |
| 01/10/2012 | US8093205 Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis |
| 01/10/2012 | US8093044 Methods for identifying inhibitors of botulinum neurotoxins |
| 01/10/2012 | US8093028 Engineered glycosyltransferases with expanded substrate specificity |
| 01/10/2012 | US8093008 Characterization of granulocytic ehrlichia and methods of use |
| 01/10/2012 | US8093007 Method for determining antagonist activity to a cytokinin receptor |
| 01/10/2012 | US8092823 Osteogenic implants with combined implant materials and methods for same |
| 01/10/2012 | US8092811 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | US8092807 Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation |
| 01/10/2012 | US8092803 VEGF antagonist formulations for intravitreal administration |
| 01/10/2012 | US8092799 Antibodies to Apo-2 receptor polypeptides |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | US8092797 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/10/2012 | US8092788 Compositions and methods for topical diagnostic and therapeutic transport |
| 01/10/2012 | US8092531 Human skin equivalents expressing exogenous polypeptides |
| 01/10/2012 | CA2528202C Process for recovering heterologous polypeptides from bacterial cells |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2400295C Modified factor viii |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/10/2012 | CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines |
| 01/10/2012 | CA2267650C Non-naturally occurring lipoprotein particle |
| 01/10/2012 | CA2262411C Resistance against nematodes and/or aphids |
| 01/10/2012 | CA2246760C Polysaccharide-peptide-conjugates |
| 01/10/2012 | CA2221342C A method and nucleotide sequence for transforming microorganisms |
| 01/10/2012 | CA2214102C Group o hiv-1, fragments of such viruses, and uses thereof |
| 01/05/2012 | WO2012003479A2 Methods for culturing undifferentiated cells using sustained release compositions |
| 01/05/2012 | WO2012003398A1 Method for uses of protein precursors as prodrugs |
| 01/05/2012 | WO2012003320A2 Flavivirus host-range mutations and uses thereof |
| 01/05/2012 | WO2012003279A2 Bioengineered protein pores |
| 01/05/2012 | WO2012002745A2 Factor viia complex using an immunoglobulin fragment |
| 01/05/2012 | WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein |
| 01/05/2012 | WO2012002562A1 Modified protein therapeutics |
| 01/05/2012 | WO2012002522A1 Therapeutic agent for indications for haloperidol, and beverage or food |
| 01/05/2012 | WO2012001712A1 Iron (iii) caseinsuccinylate and method for the preparation thereof |
| 01/05/2012 | WO2012001139A1 Variants of glucoamylase |
| 01/05/2012 | WO2012001103A1 Histone citrullinated peptides and uses thereof |
| 01/05/2012 | WO2012001101A1 Enterovirus vaccines for preventing or treating type 1 diabetes (i) |
| 01/05/2012 | WO2012001100A1 Enterovirus vaccines for preventing or treating type 1 diabetes (iii) |
| 01/05/2012 | WO2012001099A1 Enterovirus vaccines for preventing and treating type 1 diabetes (ii) |
| 01/05/2012 | WO2012001098A1 Diagnostic assay for type 1 diabetes |
| 01/05/2012 | WO2012001029A1 Gene involved in the development of the seed |
| 01/05/2012 | WO2012001004A1 Fimh vaccine against urinary tract infections (uti) |
| 01/05/2012 | WO2012001000A1 Spore surface display of bioactive molecules |
| 01/05/2012 | WO2012000906A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 01/05/2012 | WO2012000892A1 Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof |
| 01/05/2012 | WO2012000890A1 Polypeptide having beta-glucosidase activity and uses thereof |
| 01/05/2012 | WO2012000887A1 Polypeptide having swollenin activity and uses thereof |
| 01/05/2012 | WO2012000886A1 Polypeptide having beta-glucosidase activity and uses thereof |
| 01/05/2012 | WO2012000829A1 Novel proteases and compositions comprising them |
| 01/05/2012 | WO2012000459A1 Anti-hiv infection polypeptide, composition, and use |
| 01/05/2012 | WO2012000458A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 01/05/2012 | WO2012000454A1 Truncated l1 protein of human papillomavirus type 52 |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2011142858A3 Chlorotoxin variants, conjugates, and methods for their use |
| 01/05/2012 | WO2011142783A3 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain |
| 01/05/2012 | WO2011117685A3 Contraceptive peptides derived from spider venom |
| 01/05/2012 | WO2011116974A3 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | WO2011112046A3 High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein |
| 01/05/2012 | WO2011104531A3 Clostridium gene |
| 01/05/2012 | WO2011081366A9 Beef-specific age determination marker containing the p21 protein |